Printer Friendly

Articles from M2 Pharma (May 1, 2020)

1-13 out of 13 article(s)
Title Author Type Words
AMRI Increases Hydroxychloroquine Sulfate API Production in US to Meet Potential COVID-19 Demand. 160
Athersys, University Hospitals Cleveland Medical Center Activate First Clinical Site for the MACOVIA Study Evaluating MultiStem Cell Therapy for COVID-19 Induced ARDS. 1107
Babson Diagnostics Launches COVID-19 Serology Test for IgG Antibodies with 100% Specificity in Austin. 263
Bio-Rad's SARS-CoV-2 (COVID-19) Serology Test Granted FDA Emergency Use Authorization. 228
Eiger BioPharmaceuticals doses first patient in phase two study of peginterferon lambda in outpatients with mild COVID-19. 265
George Clinical collaborates with Saint Luke's Mid America Heart Institute. 161
INOVIO signs contract to expand manufacturing collaboration with Richter-Helm BioLogics for COVID-19 vaccine. 176
Medivir announces receipt of positive opinion on orphan designation in EU for drug candidate MIV-818. 166
Moderna and Lonza Team to Manufacture Moderna's Vaccine Against Novel Coronavirus. 679
Sartorius Stedim Biotech completes acquisition of selected Danaher Corporation life science businesses. 189
Sensiva Health submits US patent application for comprehensive risk stratification in response to COVID-19. 243
The Family Health Centers of Georgia Inc announces availability of COVID-19 testing for vulnerable populations in Georgia. 157
Trio Pharmaceuticals signs development collaboration agreement with Ajinomoto Bio-Pharma Services. 159

Terms of use | Privacy policy | Copyright © 2024 Farlex, Inc. | Feedback | For webmasters |